Correspondence between the CYP2C19 and CYP3A4 genotypes with the inferred metabolizer phenotype by omeprazole administration in Mexican healthy children-Reference-Cited by-同舟云学术

Correspondence between the CYP2C19 and CYP3A4 genotypes with the inferred metabolizer phenotype by omeprazole administration in Mexican healthy children

Published:2018-05-07 Issue:5 Volume:43 Page:656-663
ISSN:0269-4727
Container-title:Journal of Clinical Pharmacy and Therapeutics
language:en
Short-container-title:J Clin Pharm Ther

Author:

Favela‐Mendoza A. F.¹,Martínez‐Cortes G.¹,Romero‐Prado M. M.²,Romero‐Tejeda E. M.³,Islas‐Carbajal M. C.⁴,Sosa‐Macias M.⁵,Lares‐Asseff I.⁵,Rangel‐Villalobos H.¹

Affiliation:

1. Centro Universitario de la CienegaInstituto de Investigación en Genética MolecularUniversidad De Guadalajara Ocotlan Mexico

2. Centro Universitario de Ciencias de SaludInstituto de Terapéutica Experimental y ClínicaUniversidad De Guadalajara Guadalajara Mexico

3. Laboratorio de Investigación y Desarrollo FarmacéuticoCentro Universitario de Ciencias Exactas e IngenieríasUniversidad De Guadalajara Guadalajara Mexico

4. Centro Universitario de Ciencias de SaludUnidad de Investigación CardiovascularUniversidad De Guadalajara Guadalajara Mexico

5. Centro Interdisciplinario de Investigación para el Desarrollo Integral Regional del IPN CIIDIR‐IPNUnidad Durango Durango Mexico

Funder

Consejo Nacional de Ciencia y Tecnología

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jcpt.12699

Reference29 articles.

1. Inhibition of CYP2C19 and CYP3A4 by Omeprazole Metabolites and Their Contribution to Drug-Drug Interactions